Correspondence |

Disseminated Superficial Porokeratosis Secondary to Immunosuppression Induced by Etanercept for Extensive Psoriasis

Lucy Stewart, BMedSc, MBChB, MRCP; Alec Howat, MB BS, FRCPath; Ian Coulson, BSc, MB BS, FRCP
Arch Dermatol. 2010;146(10):1193-11974. doi:10.1001/archdermatol.2010.298.
Text Size: A A A
Published online


Jung  JYYeon  JHRyu  HSYoun  SWPark  KCHuh  CH Disseminated superficial porokeratosis developed by immunosuppression due to rheumatoid arthritis treatment. J Dermatol 2009;36 (8) 466- 467
Neumann  RAKnobler  RMMetze  DJurecka  W Disseminated superficial porokeratosis and immunosuppression. Br J Dermatol 1988;119 (3) 375- 380
Bencini  PLTarantino  AGrimalt  RPonticelli  CCaputo  R Porokeratosis and immunosuppression. Br J Dermatol 1995;132 (1) 74- 78
Tsambaos  DSpiliopoulos  T Disseminated superficial porokeratosis: complete remission subsequent to discontinuation of immunosuppression. J Am Acad Dermatol 1993;28 (4) 651- 652
Galindo  MPBartlett  BLGewirtzman  AMendoza  NTremaine  AMTyring  SK Etanercept: an overview of its role in the treatment of psoriasis. Expert Opin Drug Metab Toxicol 2008;4 (3) 305- 310
Figures in this Article

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview


Place holder to copy figure label and caption
Figure 1

One of the many lesions of porokeratosis surrounded by many small plaques of psoriasis.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2

Biopsy specimen obtained through the edge of a lesion of porokeratosis showing a parakeratotic plume (hematoxylin-eosin, original magnification ×10.

Graphic Jump Location




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Classical to current approach for treatment of psoriasis: a review. Endocr Metab Immune Disord Drug Targets 2012;12(3):287-302.